A Form 144 notice of proposed sale was filed on November 3, 2026, disclosing that Labcorp Holdings Inc. officer Bryan T. Vaughn intends to sell 306 shares of common stock through Fidelity Brokerage Services LLC.

Key Highlights

  • Seller: Bryan T. Vaughn, identified as an officer of Labcorp Holdings Inc.
  • Shares proposed for sale: 306 shares of common stock, with an aggregate market value of $108,232.20.
  • Source of shares: The 306 shares were acquired on November 1, 2026, through restricted stock vesting, classified as compensation from the issuer.
  • Approximate sale date: November 3, 2026, to be executed through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
  • Shares outstanding: According to the filing, approximately 81,200,000 shares of common stock were outstanding at the time of the notice.
  • Rule 10b5-1 plan: The filing indicates a written trading plan was adopted on March 8, 2026.
  • Prior sales: The filing reports nothing to disclose regarding securities sold during the past three months.

Proposed Sale Details for Labcorp Holdings Officer Under Rule 144

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission, Bryan T. Vaughn, an officer of Labcorp Holdings Inc. (NYSE:LH), has provided notice of a proposed sale of 306 shares of the company's common stock. The aggregate market value of the proposed sale is listed as $108,232.20. The filing states the approximate date of sale is November 3, 2026, on the New York Stock Exchange.

The filing discloses that the 306 shares were acquired on November 1, 2026, through restricted stock vesting from the issuer, with the nature of payment recorded as compensation. Vaughn reported no sales of Labcorp securities during the three months preceding this notice. The broker named in the filing is Fidelity Brokerage Services LLC, and the notice was signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Bryan Vaughn.

The filing also indicates that the sale is being made pursuant to a written trading plan adopted on March 8, 2026, in accordance with Rule 10b5-1 under the Exchange Act. Labcorp Holdings Inc. is headquartered at 358 S Main St, Burlington, North Carolina 27215, and the SEC file number listed in the filing is 001-11353.

What Was Disclosed

This Form 144 notice discloses that Labcorp Holdings officer Bryan T. Vaughn proposes to sell 306 shares of common stock valued at $108,232.20, acquired through restricted stock vesting on November 1, 2026, under a Rule 10b5-1 plan adopted March 8, 2026.